The fabrication of truly hierarchically folded single‐chain polymeric nanoparticles with primary, secondary, and defined 3D architecture is still an unfulfilled goal. In this contribution, a polymer is reported that folds into a well‐defined 3D structure from a synthetic sheet‐helix block copolymer. The sheet‐like poly(
Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher.
Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?
Some links on this page may take you to non-federal websites. Their policies may differ from this site.
-
Abstract p ‐phenylene vinylene) (PPV) block is synthesized via the ring‐opening metathesis polymerization of a thymine‐bearing dialkoxy‐substituted [2.2]paracyclophane‐1,9‐diene. The PPV block is terminated with a Pd complex using a Pd‐containing chain‐terminating agent. The terminal Pd complex catalyzes the polymerization of isocyanide monomers with side‐chains containing either a chiral menthol or an achiral diaminopyridine resulting in the formation of a helical poly(isocyanide) (PIC) random copolymer. The PIC side‐chains are capable of engaging in complementary hydrogen‐bonding with thymine units along the PPV block resulting in the folding of the two secondary structural domains into a well‐defined 3D structure. The folding and unfolding of the polymer in both chloroform and THF are monitored using dynamic light scattering and NMR spectroscopy. This work is the first example of a hierarchically folded synthetic polymer featuring a defined 3D structure achieved by using two different polymer backbones with two distinct secondary structures.Free, publicly-accessible full text available March 21, 2025 -
Abstract Poly(
p ‐phenylene vinylene)s (PPVs) and poly(arylene vinylene)s are key materials for a variety of applications ranging from organic light emitting diodes to fluorescent optical probes. Their syntheses, however, have been hampered by non‐living or step‐growth polymerization techniques. The development of functional‐group tolerant olefin metathesis catalysts has enabled the use of living ring‐opening metathesis polymerization (ROMP) of cyclophane monomers yielding PPVs and poly(p ‐phenylene‐co ‐arylene vinylene)s in a living manner. Low dispersity and soluble PPVs are afforded with control over the number of repeat units with easy incorporation of different end‐groups at their heads or tails. In this review, a comprehensive overview of tetrasubstituted and disubstituted alkyl and alkoxy containing [2.2]paracyclophane‐1,9‐diene, [2.2]metaparacyclophane‐1,9‐diene, [2.2.2]paracyclophane‐1,9,17‐triene, and benzothiadiazole‐[2.2]paracyclophane‐1,9‐diene is provided. The high ring strain of these monomers enables efficient polymerizations with ruthenium initiators. A particular emphasis is on [2.2]paracyclophane‐1,9‐dienes as it is the most investigated class of polymerized cyclophanediene since initially reported 30 years ago. Additionally, applications for soft materials synthesized by ROMP are examined, highlighting easily accessed PPV copolymers and PPV block copolymers that can be phototriggered, as well as PPVs featuring supramolecular recognition units installed at their termini to afford orthogonally self‐assembled architectures. -
null (Ed.)Novel antiviral nanotherapeutics, which may inactivate the virus and block it from entering host cells, represent an important challenge to face viral global health emergencies around the world. Using a combination of bioorthogonal copper-catalyzed 1,3-dipolar alkyne/azide cycloaddition (CuAAC) and photoinitiated thiol–ene coupling, monofunctional and bifunctional peptidodendrimer conjugates were obtained. The conjugates are biocompatible and demonstrate no toxicity to cells at biologically relevant concentrations. Furthermore, the orthogonal addition of multiple copies of two different antiviral peptides on the surface of a single dendrimer allowed the resulting bioconjugates to inhibit Herpes simplex virus type 1 at both the early and the late stages of the infection process. The presented work builds on further improving this attractive design to obtain a new class of therapeutics.more » « less